ALTERED YIN YANG 1/RAF-1 KINASE INHIBITORY PROTEIN RATIO AS A POSSIBLE MOLECULAR MARKER AND THERAPEUTIC TARGET IN HEPATOCELLULAR CARCINOMA

被引:0
|
作者
Notarbartolo, M.
Giannitrapani, L. [1 ,2 ]
Poma, P.
Labbozzetta, M.
Florena, A. M. [3 ]
Porcasi, R. [3 ]
Muggeo, V. M. R. [4 ]
Sandonato, L. [5 ]
D'Alessandro, N. [1 ]
Montalto, G.
机构
[1] Univ Palermo, Dipartimento Sci Farmacol Pietro Benigno, I-90133 Palermo, Italy
[2] Univ Palermo, Dipartimento Med Clin & Patol Emergenti, I-90133 Palermo, Italy
[3] Univ Palermo, Dipartimento Patol Umana, I-90133 Palermo, Italy
[4] Univ Palermo, Dipartimento Sci Stat & Matemat Silvio Vianelli, I-90133 Palermo, Italy
[5] Univ Palermo, Dipartimento Chirurgia Oncol, I-90133 Palermo, Italy
关键词
D O I
10.1016/S1590-8658(10)60425-2
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
T.N.20
引用
收藏
页码:S22 / S22
页数:1
相关论文
共 50 条
  • [21] Polo-like kinase 1, a new therapeutic target in hepatocellular carcinoma
    Mok, Wei Chuen
    Wasser, Shanthi
    Tan, Theresa
    Lim, Seng Gee
    WORLD JOURNAL OF GASTROENTEROLOGY, 2012, 18 (27) : 3527 - 3536
  • [22] Accumulation of the Raf-1 Kinase Inhibitory Protein (Rkip) Is Associated with Cep290-mediated Photoreceptor Degeneration in Ciliopathies
    Murga-Zamalloa, Carlos A.
    Ghosh, Amiya K.
    Patil, Suresh B.
    Reed, Nathan A.
    Chan, Lan Sze
    Davuluri, Supriya
    Peranen, Johan
    Hurd, Toby W.
    Rachel, Rivka A.
    Khanna, Hemant
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (32) : 28276 - 28286
  • [23] Downregulation of Protein Kinase D1 in hepatocellular carcinoma (HOC): Potential as a diagnostic/prognostic molecular marker
    Prakash, Preethi
    Freiz, Matt
    Bohlmeyer, Teresa
    Koch, Micheal R. D.
    Chauhan, Subhash C.
    Jaggi, Meena
    CANCER RESEARCH, 2010, 70
  • [24] Raf-1 Kinase Inhibitory Protein (RKIP) Mediates Ethanol-induced Sensitization of Secretagogue Signaling in Pancreatic Acinar Cells
    Kim, Sung Ok
    Ives, Kirk L.
    Wang, Xiaofu
    Davey, Robert A.
    Chao, Celia
    Hellmich, Mark R.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (40) : 33377 - 33388
  • [25] Protective Effect of Raf-1 Kinase Inhibitory Protein on Diabetic Retinal Neurodegeneration through P38-MAPK Pathway
    Wu, Chuanling
    Xu, Kai
    Liu, Wenqiang
    Liu, Anqi
    Liang, Huimin
    Li, Qunwang
    Feng, Zhen
    Yang, Yang
    Ding, Jiayuan
    Zhang, Tianyi
    Liu, Yingxue
    Liu, Xuezheng
    Zuo, Zhongfu
    CURRENT EYE RESEARCH, 2022, 47 (01) : 135 - 142
  • [26] Clinical implications for loss or diminution of expression of Raf-1 kinase inhibitory protein and its phosphorylated form in ductal breast cancer
    Al-Mulla, Fahd
    Bitar, Milad S.
    Thiery, Jean Paul
    Zea, Tan Tuan
    Chatterjee, Devasis
    Bennett, Lindsay
    Park, Sungdae
    Edwards, Joanne
    Yeung, Kam C.
    AMERICAN JOURNAL OF CANCER RESEARCH, 2013, 3 (05): : 446 - 464
  • [27] The expression of tuftelin 1 as a new theranostic marker in early diagnosis and as a therapeutic target in hepatocellular carcinoma
    Abdel-Hamid, Nabil M.
    Zakaria, Sherin M.
    Ansary, Abeer M.
    El-Senduny, Fardous F.
    El-Shishtawy, Mamdouh M.
    CELL BIOCHEMISTRY AND FUNCTION, 2023, 41 (07) : 788 - 800
  • [28] Clinical significance of raf-1 kinase inhibitor protein in oral squamous cell carcinoma and its role in cell metastasis
    Lu, M-M
    Guo, X-J
    Lyu, C-Q
    Zou, D-R
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2020, 24 (23) : 12194 - 12199
  • [29] Raf-1 independent stimulation of mitogen-activated protein kinase by leukemia inhibitory factor in 3T3-L1 cells
    William P Schiemann
    Neil M Nathanson
    Oncogene, 1998, 16 : 2671 - 2679
  • [30] Raf-1 independent stimulation of mitogen-activated protein kinase by leukemia inhibitory factor in 3T3-L1 cells
    Schiemann, WP
    Nathanson, NM
    ONCOGENE, 1998, 16 (20) : 2671 - 2679